Hyper-responsiveness of IPF/UIP fibroblasts: Interplay between TGFβ1, IL-13 and CCL2

International Journal of Biochemistry and Cell Biology

Volumn 40, Issue 10, 2008, Pages 2174-2182

  Murray, Lynne A ^a   Argentieri, Rochelle L ^a   Farrell, Francis X ^a   Bracht, Michelle ^a   Sheng, Hai ^a   Whitaker, Brian ^a   Beck, Heena ^a   Tsui, Ping ^a   Cochlin, Karyn ^a   Evanoff, Holly L ^b   Hogaboam, Cory M ^b   Das, Anuk M ^a  

^a CENTOCOR INC   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Chemokine; Fibroblast; Pulmonary fibrosis

Indexed keywords

BLEOMYCIN; COLLAGEN; CYTOKINE; INTERLEUKIN 13; JE PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 5; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLLAGEN METABOLISM; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; FIBROSING ALVEOLITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INTERSTITIAL PNEUMONIA; LUNG DEPOSIT; LUNG FIBROBLAST; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; RECEPTOR UPREGULATION; STIMULATION;

ACTINS; ANIMALS; ANTIBODIES; CELL LINE; CHEMOKINE CCL2; COLLAGEN; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-13; MICE; MICE, INBRED C57BL; MONOCYTE CHEMOATTRACTANT PROTEINS; NEUTRALIZATION TESTS; PHENOTYPE; PULMONARY FIBROSIS; RECEPTORS, GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

MURINAE;

EID: 48949117336     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2008.02.016     Document Type: Article

References (44)

1. Antoniades H.N., Bravo M.A., Avila R.E., Galanopoulos T., Neville-Golden J., Maxwell M., et al. Platelet-derived growth factor in idiopathic pulmonary fibrosis. J Clin Invest 86 4 (1990) 1055-1064
2. Asano Y., Ihn H., Yamane K., Jinnin M., Mimura Y., and Tamaki K. Increased expression of integrin alpha(v)beta3 contributes to the establishment of autocrine TGF-beta signaling in scleroderma fibroblasts. J Immunol 175 11 (2005) 7708-7718
3. Asano Y., Ihn H., Yamane K., Jinnin M., and Tamaki K. Increased expression of integrin alphavbeta5 induces the myofibroblastic differentiation of dermal fibroblasts. Am J Pathol 168 2 (2006) 499-510
4. Bensadoun E.S., Burke A.K., Hogg J.C., and Roberts C.R. Proteoglycan deposition in pulmonary fibrosis. Am J Respir Crit Care Med 154 6 Pt 1 (1996) 1819-1828
5. Blease K., Schuh J.M., Jakubzick C., Lukacs N.W., Kunkel S.L., Joshi B.H., et al. Stat6-deficient mice develop airway hyperresponsiveness and peribronchial fibrosis during chronic fungal asthma. Am J Pathol 160 2 (2002) 481-490
6. Burdick M.D., Murray L.A., Keane M.P., Xue Y.Y., Zisman D.A., Belperio J.A., et al. CXCL11 attenuates bleomycin-induced pulmonary fibrosis via inhibition of vascular remodeling. Am J Respir Crit Care Med 171 3 (2005) 261-268
7. Carulli M.T., Ong V.H., Ponticos M., Shiwen X., Abraham D.J., Black C.M., et al. Chemokine receptor CCR2 expression by systemic sclerosis fibroblasts: Evidence for autocrine regulation of myofibroblast differentiation. Arthritis Rheum 52 12 (2005) 3772-3782
8. Chambers R.C., Leoni P., Kaminski N., Laurent G.J., and Heller R.A. Global expression profiling of fibroblast responses to transforming growth factor-beta1 reveals the induction of inhibitor of differentiation-1 and provides evidence of smooth muscle cell phenotypic switching. Am J Pathol 162 2 (2003) 533-546
9. Coultas D.B., Zumwalt R.E., Black W.C., and Sobonya R.E. The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med 150 4 (1994) 967-972
10. Dacic S., and Yousem S.A. Histologic classification of idiopathic chronic interstitial pneumonias. Am J Respir Cell Mol Biol 29 3 Suppl. (2003) S5-S9
11. Desmouliere A., Redard M., Darby I., and Gabbiani G. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 146 1 (1995) 56-66
12. Duncan M.R., Frazier K.S., Abramson S., Williams S., Klapper H., Huang X., et al. Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: Down-regulation by camp. FASEB J 13 13 (1999) 1774-1786
13. Fichtner-Feigl S., Strober W., Kawakami K., Puri R.K., and Kitani A. IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis. Nat Med 12 1 (2006) 99-106
14. Fine A., and Goldstein R.H. The effect of transforming growth factor-beta on cell proliferation and collagen formation by lung fibroblasts. J Biol Chem 262 8 (1987) 3897-3902
15. Flaherty K.R., Travis W.D., Colby T.V., Toews G.B., Kazerooni E.A., Gross B.H., et al. Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med 164 9 (2001) 1722-1727
16. Gharaee-Kermani M., McCullumsmith R.E., Charo I.F., Kunkel S.L., and Phan S.H. CC-chemokine receptor 2 required for bleomycin-induced pulmonary fibrosis. Cytokine 24 6 (2003) 266-276
17. Hancock A., Armstrong L., Gama R., and Millar A. Production of interleukin 13 by alveolar macrophages from normal and fibrotic lung. Am J Respir Cell Mol Biol 18 1 (1998) 60-65
18. Hasegawa M., Fujimoto M., Kikuchi K., and Takehara K. Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis. J Rheumatol 24 2 (1997) 328-332
19. Hasegawa M., Sato S., Nagaoka T., Fujimoto M., and Takehara K. Serum levels of tumor necrosis factor and interleukin-13 are elevated in patients with localized scleroderma. Dermatology 207 2 (2003) 141-147
20. Hogaboam C.M., Bone-Larson C.L., Lipinski S., Lukacs N.W., Chensue S.W., Strieter R.M., et al. Differential monocyte chemoattractant protein-1 and chemokine receptor 2 expression by murine lung fibroblasts derived from Th1- and Th2-type pulmonary granuloma models. J Immunol 163 4 (1999) 2193-2201
21. Ingram J.L., Rice A.B., Geisenhoffer K., Madtes D.K., and Bonner J.C. IL-13 and IL-1beta promote lung fibroblast growth through coordinated up-regulation of PDGF-AA and PDGF-Ralpha. FASEB J 18 10 (2004) 1132-1134
22. Ingram J.L., Antao-Menezes A., Mangum J.B., Lyght O., Lee P.J., Elias J.A., et al. Opposing actions of Stat1 and Stat6 on IL-13-induced up-regulation of early growth response-1 and platelet-derived growth factor ligands in pulmonary fibroblasts. J Immunol 177 6 (2006) 4141-4148
23. Iyonaga K., Takeya M., Saita N., Sakamoto O., Yoshimura T., Ando M., et al. Monocyte chemoattractant protein-1 in idiopathic pulmonary fibrosis and other interstitial lung diseases. Hum Pathol 25 5 (1994) 455-463
24. Jakubzick C., Choi E.S., Carpenter K.J., Kunkel S.L., Evanoff H., Martinez F.J., et al. Human pulmonary fibroblasts exhibit altered interleukin-4 and interleukin-13 receptor subunit expression in idiopathic interstitial pneumonia. Am J Pathol 164 6 (2004) 1989-2001
25. Jakubzick C., Choi E.S., Kunkel S.L., Evanoff H., Martinez F.J., Puri R.K., et al. Augmented pulmonary IL-4 and IL-13 receptor subunit expression in idiopathic interstitial pneumonia. J Clin Pathol 57 5 (2004) 477-486
26. Katzenstein A.L., and Myers J.L. Idiopathic pulmonary fibrosis: Clinical relevance of pathologic classification. Am J Respir Crit Care Med 157 4 Pt 1 (1998) 1301-1315
27. Keane M.P., Belperio J.A., Arenberg D.A., Burdick M.D., Xu Z.J., Xue Y.Y., et al. IFN-gamma-inducible protein-10 attenuates bleomycin-induced pulmonary fibrosis via inhibition of angiogenesis. J Immunol 163 10 (1999) 5686-5692
28. Kubo M., Ihn H., Yamane K., and Tamaki K. Upregulated expression of transforming growth factor-beta receptors in dermal fibroblasts of skin sections from patients with systemic sclerosis. J Rheumatol 29 12 (2002) 2558-2564
29. Kuhn C., and McDonald J.A. The roles of the myofibroblast in idiopathic pulmonary fibrosis. Ultrastructural and immunohistochemical features of sites of active extracellular matrix synthesis. Am J Pathol 138 5 (1991) 1257-1265
30. Low R.B., Giancola M.S., King Jr. T.E., Chapitis J., Vacek P., and Davis G.S. Serum and bronchoalveolar lavage of N-terminal type III procollagen peptides in idiopathic pulmonary fibrosis. Am Rev Respir Dis 146 3 (1992) 701-706
31. Moodley Y.P., Misso N.L., Scaffidi A.K., Fogel-Petrovic M., McAnulty R.J., Laurent G.J., et al. Inverse effects of interleukin-6 on apoptosis of fibroblasts from pulmonary fibrosis and normal lungs. Am J Respir Cell Mol Biol 29 4 (2003) 490-498
32. Moore B.B., Paine III R., Christensen P.J., Moore T.A., Sitterding S., Ngan R., et al. Protection from pulmonary fibrosis in the absence of CCR2 signaling. J Immunol 167 8 (2001) 4368-4377
33. Moore B.B., Kolodsick J.E., Thannickal V.J., Cooke K., Moore T.A., Hogaboam C., et al. CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury. Am J Pathol 166 3 (2005) 675-684
34. Moore B.B., Murray L., Das A., Wilke C.A., Herrygers A.B., and Toews G.B. The role of CCL12 in the recruitment of fibrocytes and lung fibrosis. Am J Respir Cell Mol Biol 35 2 (2006) 175-181
35. Oemar B.S., and Luscher T.F. Connective tissue growth factor. Friend or foe?. Arterioscler Thromb Vasc Biol 17 8 (1997) 1483-1489
36. Ohta K., Mortenson R.L., Clark R.A., Hirose N., and King Jr. T.E. Immunohistochemical identification and characterization of smooth muscle-like cells in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 152 5 Pt 1 (1995) 1659-1665
37. Oriente A., Fedarko N.S., Pacocha S.E., Huang S.K., Lichtenstein L.M., and Essayan D.M. Interleukin-13 modulates collagen homeostasis in human skin and keloid fibroblasts. J Pharmacol Exp Ther 292 3 (2000) 988-994
38. Phan S.H. The myofibroblast in pulmonary fibrosis. Chest 122 6 Suppl. (2002) 286S-289S
39. Saito A., Okazaki H., Sugawara I., Yamamoto K., and Takizawa H. Potential action of IL-4 and IL-13 as fibrogenic factors on lung fibroblasts in vitro. Int Arch Allergy Immunol 132 2 (2003) 168-176
40. Strieter R.M., Starko K.M., Enelow R.I., Noth I., and Valentine V.G. Effects of interferon-gamma 1b on biomarker expression in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 170 2 (2004) 133-140
41. Suga M., Iyonaga K., Ichiyasu H., Saita N., Yamasaki H., and Ando M. Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases. Eur Respir J 14 2 (1999) 376-382
42. Tanaka T., Yoshimi M., Maeyama T., Hagimoto N., Kuwano K., and Hara N. Resistance to Fas-mediated apoptosis in human lung fibroblast. Eur Respir J 20 2 (2002) 359-368
43. Travis W.D., Matsui K., Moss J., and Ferrans V.J. Idiopathic nonspecific interstitial pneumonia: Prognostic significance of cellular and fibrosing patterns: Survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am J Surg Pathol 24 1 (2000) 19-33
44. Zhu Z., Ma B., Zheng T., Homer R.J., Lee C.G., Charo I.F., et al. IL-13-induced chemokine responses in the lung: Role of CCR2 in the pathogenesis of IL-13-induced inflammation and remodeling. J Immunol 168 6 (2002) 2953-2962